Skip to content
AnalystLens

METLIFE INC 8-K Report, Regulation FD Disclosure (Sep 24, 2026)

Reports
Regulation FD
Filing Date
Filed September 24, 2026
Period End
September 24, 2026
In the record · 2016–202610-K1110-Q328-K249

MET filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 249 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Aug ’17Aug ’17
  2. Leadership change8-K · Mar ’19Mar ’19
  3. Material agreement8-K · Mar ’21Mar ’21
  4. Leadership change8-K · Jul ’25Jul ’25

Summary

Summary of the 8-K filed September 24, 2026. Cited figures are marked; the original filing is the authoritative source.

MetLife, Inc. has issued an 8-K filing to provide preliminary insights into its variable investment income for the third quarter of 2026, ahead of its official earnings release.

The company estimates this income to be at least $600 milliona (pre-tax). This figure provides investors with an early indication of performance in key alternative investment areas, including private equity, real estate, and prepayment fees. While this disclosure offers a glimpse into a specific component of MetLife's revenue, it's crucial for investors to understand that these are preliminary, unaudited results.

The company explicitly cautions that actual results may differ materially from these estimates. Investors should exercise caution and not rely solely on this information, as it is not a substitute for the full financial statements prepared under U.S. GAAP, which will be released on November 4, 2026.

Key Highlights

  1. MetLife provides a preliminary estimate of variable investment income for Q3 2026, projecting at least $600 million (pre-tax).
  2. This estimate covers income from private equity, real estate, and other funds, as well as prepayment fees.
  3. The Q3 2026 estimate is part of the company's full-year 2026 guidance of approximately $1.6 billion (pre-tax) for variable investment income.
  4. The disclosed figures are preliminary and unaudited; actual results could differ materially.
  5. Investors are advised to exercise caution and await the full, U.S. GAAP-compliant financial statements.
  6. The full quarterly earnings release and financial supplement are scheduled for November 4, 2026.
  7. This information is furnished under Regulation FD and is not considered 'filed' for purposes of Section 18 of the Exchange Act.

Frequently Asked Questions

  1. What is variable investment income, and why is MetLife disclosing it?

    Variable investment income for MetLife includes earnings from investments in private equity, real estate funds, other alternative investments, and prepayment fees. The company is disclosing preliminary figures to provide investors with an early look at this component of their financial performance before the official quarterly earnings release.

  2. How significant is the estimated $600 million in variable investment income for the third quarter?

    The estimated $600 million (pre-tax) for the third quarter represents a substantial portion of the company's full-year guidance of approximately $1.6 billion (pre-tax) for variable investment income. This suggests that this segment is performing solidly in the third quarter, though these are preliminary estimates.

  3. Are these preliminary results final and reliable?

    No, these are preliminary and unaudited estimates based on information available to management at the time of the filing. MetLife explicitly states that actual results could be materially different, and investors should not rely solely on this information. The definitive and audited financial results will be available in the company's full quarterly earnings release on November 4, 2026.

  4. Where can I find the complete and audited financial results?

    The complete and audited financial results for the quarter ended September 30, 2026, along with a quarterly financial supplement, are scheduled to be released by MetLife on November 4, 2026. Investors should refer to that official release and subsequent filings for comprehensive financial data.